This message was sent to ##Email## March 28, 2019     Home  |   About   Subscribe  |   Archive  |   Advertise   American College of Radiology seeks surgeons to serve on appropriateness criteria committees The American College of Radiology (ACR) Committee on Appropriateness Criteria (AC) is seeking surgeon volunteers to serve on ACR AC committees. Breast surgeon volunteers are needed for the following four committees: Imaging after Mastectomy and Breast Reconstruction Imaging of the Axilla Transgender Breast Imaging Supplemental Screening Based on Breast Density In addition, surgeon volunteers are needed for: Radiologic Management of Hepatic Malignancy (liver or transplant surgeon) Parathyroid Adenoma (neurosurgeon) Postoperative Bleed, Concern for Retroperitoneal Bleed (vascular surgeon) The ACR AC are evidence-based guidelines to assist referring physicians and other providers in making the most appropriate imaging or treatment decision for a specific clinical condition. Employing these guidelines helps providers enhance quality of care and contribute to the most efficacious use of radiology. All the ACR AC topics as well as additional information about the program can be found online. Individuals should send an e-mail outlining their interest along with their CV to Connie Bura at cbura@facs.org by Friday, April 5. READ MORE    SPONSORED CONTENT Advertisement Promoted by CHAMPS Oncology CHAMPS Oncology: Discover Who We Are We Transform Your Cancer Data with insight2oncology® We Provide a Greater Value with Our Registry Solutions We Blog Regularly at CHAMPS Oncology Outlook We Don’t Just Provide CTR Jobs, We Cultivate Cancer Registry Careers   ACS Committee Opportunities The American College of Surgeons (ACS) Commission on Cancer and Clinical Research Program depend on volunteers from its diverse membership to drive the mission and initiatives of the organization and the surgical profession. Serving on a Commission on Cancer or Clinical Research Program Committee is a great way to contribute to program initiatives, network with colleagues, advance into leadership positions, and contribute to improvements in cancer patient care. The ACS COMMITTEE OPPORTUNITIES web page includes information about those ACS Committees, that include the Commission on Cancer and Clinical Research Program, that are looking for new surgeon members to serve. Visit the ACS Committee Opportunities web page for details on what’s involved and how to apply. The deadline for applications is May 31. READ MORE Last chance to pre-register for the Accreditation 101 programs Pre-registration for the Accreditation 101 programs of the Commission on Cancer (CoC), National Accreditation Program for Breast Centers (NAPBC), and/or National Accreditation Program for Rectal Cancer (NAPRC) ends on April 1. Onsite registration will be available for each of these programs. Learn the basics of CoC, NAPBC and NAPRC accreditation by attending one, two, or all three days on April 7–9, in Rosemont, IL. Each program has been approved for a minimum of 6.25 CME, and application has been submitted to NCRA for CEs. Learn more by visiting the Cluster Programs web page.    SERVICE SHOWCASE Advertisement Help Doctors Without Borders Today Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more Cancer Programs staff on the road Staff from the Cancer Programs look forward to seeing you at the Cancer Programs booth during the following conferences: Society of Surgical Oncology (SSO), March 27–30 in San Diego, Booth 604 ACS Leadership and Advocacy Summit, Washington DC, March 29-April 1 American Society of Breast Surgeons, April 30–May 5 in Dallas, Booth 404 National Cancer Registrars Association (NCRA), May 19–22 in Denver, Booth 33 ASCO Annual, May 31–June 4 in Chicago, Booth 22122 American Society for Colon and Rectal Surgeons, June 1–5 in Cleveland, Booth 635 Please stop by and learn what’s new from the Cancer Programs.  NCDB NEWS CTR Guide to Coding Radiation Therapy The Commission on Cancer Radiation Oncology Working Group is pleased to announce the distribution of the CTR Guide to Coding Radiation Therapy Treatment in the STORE version 1.0 to aid registrars in the coding of the 31 radiation data items defined in STORE. This document may also be found in the Resources section of the National Cancer Database web page. READ MORE Call for Data 2019 GenEDITS Plus 5 The 2019 GenEDITS Plus 5 Installation and Edits v16 and v18 guide is now available. GenEDITS Plus is a tool developed by the Centers for Disease Control and Prevention (CDC) used for defining standards for data quality and for checking data quality during the collection process. Programs submitting data for the 2019 Call for Data should use GenEDITS Plus as a final check of edits before submitting to the NCDB. Once the files are clean of edit errors, rename and submit through the CoC Datalinks submission portal. Download and install GenEDITS Plus 5 from the CDC website. Assistance from your program’s IT department may be needed. Additional information is posted in the 2019 GenEDITS Plus 5 editing software page. READ MORE     .  SPONSOR SPOTLIGHT Advertisement      HEALTH CARE NEWS AND UPDATES Immunotherapy improves prognosis for recurrent ovarian cancer patients Precision Vaccinations The findings from a recent clinical trial show that a new immunotherapy treatment, when added to standard chemotherapy, significantly prolongs survival in women with recurrent ovarian cancer. This randomized phase II clinical trial showed women treated with a combination of chemotherapy and immunotherapy experienced significantly prolonged survival.  READ MORE Maintenance rucaparib effective for all age groups in ovarian cancer, but safety questioned Cancer Network Rucaparib, a poly polymerase inhibitor, was effective as a maintenance therapy across all age groups of patients with recurrent ovarian cancer, according to the results of a post-hoc exploratory analysis of ARIEL3 presented at the 2019 Society of Gynecologic Oncology 50th Annual Meeting on Women’s Cancer, held March 16-19 in Honolulu, Hawaii. However, despite this, the toxicity of rucaparib may be too high for a maintenance therapy, particularly among older patients who saw the least clinical benefit.  READ MORE    SPONSORED CONTENT Advertisement Promoted by InformedDNA What’s Ahead for Precision Medicine? Trends Point to More Automated Decision Support Precision Medicine: A Glossary of Terms How Medicare Coverage of Genetic Counseling Could Decrease Care Costs and Improve Quality Genetic Counseling services from the nation’s largest, lab-independent, full-time staff of certified genetics experts in the U.S. Whitepaper: Eliminating the Hidden Costs of Genetic Testing Claims   This common 'supermaterial' may help detect cancer MDLinx The “supermaterial” graphene may be the key to advanced detection of early-stage lung cancer in the future, according to researchers from the University of Exeter, United Kingdom. They recently developed a highly sensitive graphene biosensor that can detect common lung cancer biomarkers, and published their results in Nanoscale  READ MORE Why immunotherapy is not effective for some patients with metastatic melanoma and kidney cancer ScienceDaily White blood cells known as B cells have been shown to be effective for predicting which cancer patients will respond to immune checkpoint blockade therapy, according to a study at The University of Texas MD Anderson Cancer Center. The study, led by Jennifer Wargo, M.D., professor in the Surgical Oncology and Genomic Medicine, found that some B cells with unique characteristics predicted response and may be contributing mechanistically to the immune system's response.  READ MORE .  PRODUCT SHOWCASE VTI 8 MHz Surgical Doppler The VTI 8 MHz Surgical Doppler is FDA cleared for intraoperative evaluation of vasculature, unlike some other Doppler systems. The sterile, single-use probes help to ensure your patient's safety, offer reliability with every use, and can be itemized as a billable supply. Patient-nurse communication is key in ovarian cancer Oncology Nursing News Having honest conversations about treatment choices and adverse events is key for oncology nurses treating patients with ovarian cancer, explained Paula Anastasia. Anastasia is a gynecologic oncology clinical nurse specialist at Cedars Sinai Medical Center in Los Angeles and a recipient of CURE’s 2019 Ovarian Cancer Heroes award at a March event in Honolulu, Hawaii, held on the eve of the 50th Society of Gynecologic Oncology Annual Meeting on Women’s Cancers.  READ MORE Prevalence, immunotherapy use in anorectal mucosal melanoma found to be increasing Cancer Therapy Advisor Prevalence of anorectal mucosal melanoma has increased. In addition, use of immunotherapy to treat the disease has also increased over an 11-year period, results from a retrospective study has shown. Mucosal melanomas in general, and ARMM in particular, represent rare forms of melanoma with very poor prognoses. The main objectives of this study were to investigate the prevalence of this disease and discern whether specific management practice trends exist.  READ MORE Potential game changer for endometrial cancer MedPage Today An investigational PD-1 inhibitor achieved objective responses in 30 percent of patients with recurrent or advanced endometrial cancer, according to a study. The overall response rate included almost half of patients with microsatellite instability-high (MSI-H) tumors. Dostarlimab produced responses in patients with MSI-H, microsatellite stable and microsatellite status unknown tumors.  READ MORE Immunotherapy likely to become standard for recurrent/metastatic head and neck cancers Healio The standard treatment for patients with recurrent or metastatic head and neck cancers is expected to change from chemotherapy to immunotherapy based on results of several randomized, phase 3 studies, according to a presenter at HemOnc Today New York. It is still unknown whether a regimen of immunotherapy and chemotherapy could become the standard of care.  READ MORE Are preventive drugs overused at the end of life in older adults with cancer? Science Codex A new study reveals that preventive medications — such as those to lower blood pressure or cholesterol, or to protect bone health, among others — are commonly prescribed during the last year of life of older adults with cancer, even though they are unlikely to provide meaningful benefits. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for efforts to reduce the burden of drugs with limited clinical benefit near the end of life.  READ MORE Mouse study yields long-awaited insights into human stomach cancer Medical Xpress Mice have been instrumental in the study of cancer, but like all animal models of human diseases, they have their limitations. For stomach cancer in particular, mice have historically been regarded as quite poor research organisms because rodents rarely develop spontaneous stomach tumors.  READ MORE  IMPORTANT DATES AND DEADLINES Date Event March 30 - April 2 ACS Leadership & Advocacy Summit, Washington, DC April 1 NCDB Call for Data Opens April 2-6 American College of Medical Genetics and Genomics, Seattle, WA April 3-6 Hematology/Oncology Pharmacy Association, Fort Worth, TX April 4-5 Community Oncology Alliance, Orlando, FL April 4-7 Society Breast Imaging, Hollywood, FL April 6-9 American Radium Society, Fort Worth, TX April 7 Cancer Programs Pursuing Excellence Through NAPRC Accreditation, Rosemont, IL April 8 Cancer Programs - CoC Accreditation 101, Rosemont, IL April 9 Cancer Programs - NAPRC Accreditation 101, Rosemont, IL April 7-9 American Association of Endocrine Surgeons, Los Angeles, CA April 8-10 Association of Pediatric Oncology Social Workers, Phoenix, AZ April 8-12 National Cancer Registrars Week sponsored by NCRA April 11-13 American College of Physicians, Philadelphia, PA April 11-14 Oncology Nursing Society, Anaheim, CA April 30 - May 5 American Society of Breast Surgeons, Dallas, TX June 2 National Cancer Survivors Day July 19-22 ACS Quality and Safety Conference, Washington, DC Oct. 1-31 National Breast Cancer Awareness Month Oct. 27-31 ACS Clinical Congress, San Francisco, CA   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the American College of Surgeons Cancer Programs from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The American College of Surgeons and Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063